Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation
Journal of the American College of Cardiology · 2024-05 · 83 (20) · 2002-2014
DOI: 10.1016/j.jacc.2024.02.045 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American College of Cardiology, 2024-05. Verfasst von Rebecca T Hahn und 22 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Irving Medical Center, New York, New York, USA; Cardiovascular Research Foundation, New York, New York, USA. Electronic address: …. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Defibrillators, Implantable, Pacemaker, Artificial. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
Orthotopic transcatheter tricuspid valve replacement (TTVR) devices have been shown to be highly effective in reducing tricuspid regurgitation (TR), and interest in this therapy is growing with the recent commercial approval of the first orthotopic TTVR. Recent TTVR studies report preexisting cardiac implantable electronic device (CIED) transvalvular leads in ∼35% of patients, with entrapment during valve implantation. Concerns have been raised regarding the safety of entrapping leads and counterbalanced against the risks of transvenous lead extraction (TLE) when indicated. This Heart Valve Collaboratory consensus document attempts to define the patient population with CIED lead-associated or lead-induced TR, describe the risks of lead entrapment during TTVR, delineate the risks and benefits of TLE in this setting, and develop a management algorithm for patients considered for TTVR. An electrophysiologist experienced in CIED management should be part of the multidisciplinary heart team and involved in shared decision making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Columbia University Irving Medical Center, New York, New York, USA; Cardiovascular Research Foundation, New York, New York, USA. Electronic address: rth2@cumc.columbia.edu.
- Cleveland Clinic, Cleveland, Ohio, USA.
- Columbia University Irving Medical Center, New York, New York, USA.
- University of California-San Diego, San Diego, California, USA.
- University of Michigan, Ann Arbor, Michigan, USA.
- University of Chicago Medicine, Chicago, Illinois, USA.
Zitieren
APA
Hahn, R. T., Wilkoff, B. L., Kodali, S., Birgersdotter-Green, U. M., Ailawadi, G., Addetia, K., Andreas, M., Auricchio, A., Ehlert, F., George, I., Gupta, A., Harrison, R., Ho, E. C., Kusumoto, F., Latib, A., O'Gara, P., Patton, K. K., Pinney, S., Zeitler, E. P., …, & Heart Valve Collaboratory and Heart Rhythm Society (2024). Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation. Journal of the American College of Cardiology, 83(20), 2002-2014. https://doi.org/10.1016/j.jacc.2024.02.045
Vancouver
Hahn RT, Wilkoff BL, Kodali S, Birgersdotter-Green UM, Ailawadi G, Addetia K, et al. Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation. Journal of the American College of Cardiology. 2024;83(20):2002-2014. doi:10.1016/j.jacc.2024.02.045
BibTeX
@article{Hahn2024,
author = {Hahn, Rebecca T and Wilkoff, Bruce Larry and Kodali, Susheel and Birgersdotter-Green, Ulrika Maria and Ailawadi, Gorav and Addetia, Karima and Andreas, Martin and Auricchio, Angelo and Ehlert, Frederick and George, Isaac and Gupta, Aakriti and Harrison, Rachel and Ho, Edwin C and Kusumoto, Fred and Latib, Azeem and O'Gara, Patrick and Patton, Kristen K and Pinney, Sean and Zeitler, Emily P and Mack, Michael J and Leon, Martin B and Epstein, Laurence M and Heart Valve Collaboratory and Heart Rhythm Society, Heart Valve Collaboratory and Heart Rhythm Society},
title = {Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation},
journal = {Journal of the American College of Cardiology},
year = {2024},
volume = {83},
number = {20},
pages = {2002--2014},
doi = {10.1016/j.jacc.2024.02.045}
}
EUVIMED